Memory deficits with intact cognitive control in the methylazoxymethanol acetate (MAM) exposure model of neurodevelopmental insult

被引:10
|
作者
O'Reilly, Kally C. [1 ]
Perica, Maria I. [1 ]
Fenton, Andre A. [1 ,2 ]
机构
[1] NYU, Ctr Neural Sci, 4 Washington Pl, New York, NY 10003 USA
[2] Suny Downstate Med Ctr, Dept Physiol, Brooklyn, NY 11203 USA
关键词
MAM; Methylazoxymethanol acetate; Neurodevelopmental insult; Cognition; Spatial memory; Hyperactivity; Schizophrenia; FMR1 KNOCKOUT MICE; WATER MAZE; SPATIAL INFORMATION; TRANSGENIC MICE; ADULT RATS; SCHIZOPHRENIA; NAVIGATION; TASK; NMDA; HIPPOCAMPUS;
D O I
10.1016/j.nlm.2016.07.034
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Cognitive impairments are amongst the most debilitating deficits of schizophrenia and the best predictor of functional outcome. Schizophrenia is hypothesized to have a neurodevelopmental origin, making animal models of neurodevelopmental insult important for testing predictions that early insults will impair cognitive function. Rats exposed to methylazoxymethanol acetate (MAM) at gestational day 17 display morphological, physiological and behavioral abnormalities relevant to schizophrenia. Here we investigate the cognitive abilities of adult MAM rats. We examined brain activity in MAM rats by histochemically assessing cytochrome oxidase enzyme activity, a metabolic marker of neuronal activity. To assess cognition, we used a hippocampus-dependent two-frame active place avoidance paradigm to examine learning and spatial memory, as well as cognitive control and flexibility using the same environment and evaluating the same set of behaviors. We confirmed that adult MAM rats have altered hippocampal morphology and brain function, and that they are hyperactive in an open field. The latter likely indicates MAM rats have a sensorimotor gating deficit that is common to many animal models used for schizophrenia research. On first inspection, cognitive control seems impaired in MAM rats, indicated by more errors during the two-frame active place avoidance task. Because MAM rats are hyperactive throughout place avoidance training, we considered the possibility that the hyperlocomotion may account for the apparent cognitive deficits. These deficits were reduced on the basis of measures of cognitive performance that account for motor activity differences. However, though other aspects of memory are intact, the ability of MAM rats to express trial-to-trial memory is delayed compared to control rats. These findings suggest that spatial learning and cognitive abilities are largely intact, that the most prominent cognitive deficit is specific to acquiring memory in the MAM neurodevelopmental model, and that hyperactivity can confound assessments of cognition in animal models of mental dysfunction. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:294 / 303
页数:10
相关论文
共 50 条
  • [1] NEONATAL TREATMENT WITH METHYLAZOXYMETHANOL ACETATE (MAM) AS A NEURODEVELOPMENTAL MODEL OF SCHIZOPHRENIA: BEHAVIORAL, PHARMACOLOGICAL AND MORPHOLOGICAL CHARACTERIZATION
    Basso, Ana M.
    Curzon, Peter
    Zhang, Min
    Gallagher, Kelly B.
    Salte, Katherine
    Brown, Jordan
    Nikkel, Arthur L.
    Bitner, R. Scott
    Day, Mark
    Decker, Michael W.
    Fox, Gerard B.
    Rueter, Lynne E.
    Chin, Chih-Liang
    SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 272 - 273
  • [2] Prenatal methylazoxymethanol treatment in the rat: A neurodevelopmental model for studying cognitive deficits in schizophrenia?
    Gourevitch, R
    Jay, TM
    Le Pen, G
    Rocher, C
    Krebs, MO
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 57 - 57
  • [3] Cognitive deficits in rats exposed to methylazoxymethanol (MAM) on gestational day 17; A preclinical model of schizophrenia
    Flagstad, P
    Glenthoj, B
    Didriksen, M
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S435 - S436
  • [4] Behavioral, histological and electrophysiological effects of prenatal methylazoxymethanol acetate (MAM) exposure on female mice
    Chalkiadaki, K.
    Kollias, A.
    Chatzaki, E.
    Sidiropoulou, K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S286 - S287
  • [5] The prenatal methylazoxymethanol acetate treatment:: a neurodevelopmental animal model for schizophrenia?
    Jongen-Rêlo, AL
    Leng, A
    Lüber, M
    Pothuizen, HHJ
    Weber, L
    Feldon, J
    BEHAVIOURAL BRAIN RESEARCH, 2004, 149 (02) : 159 - 181
  • [6] Prenatal treatment with methylazoxymethanol acetate as a neurodevelopmental disruption model of schizophrenia in mice
    Takahashi, Kohei
    Nakagawasai, Osamu
    Sakuma, Wakana
    Nemoto, Wataru
    Odaira, Takayo
    Lin, Jia-Rong
    Onogi, Hiroshi
    Srivastava, Lalit K.
    Tan-No, Koichi
    NEUROPHARMACOLOGY, 2019, 150 : 1 - 14
  • [7] INCREASED ACTIVITY AND AVERSIVELY MOTIVATED ACQUISITION DEFICITS IN RATS WITH PRENATALLY INDUCED MICRENCEPHALY FROM METHYLAZOXYMETHANOL (MAM) ACETATE
    VORHEES, CV
    FERNANDEZ, K
    DUMAS, RM
    HADDAD, RK
    TERATOLOGY, 1983, 27 (02) : A82 - A82
  • [8] PRENATAL EXPOSURE TO METHYLAZOXYMETHANOL (MAM) ACETATE - EFFECTS ON ULTRASONIC VOCALIZATION AND LOCOMOTOR-ACTIVITY IN RAT OFFSPRING
    CAGIANO, R
    DESALVIA, M
    RENNA, G
    RACAGNI, G
    CUOMO, V
    ARCHIVES OF TOXICOLOGY, 1987, : 148 - 151
  • [9] The Methylazoxymethanol Acetate (MAM-E17) Rat Model: Molecular and Functional Effects in the Hippocampus
    Hradetzky, Eva
    Sanderson, Thomas M.
    Tsang, Tsz M.
    Sherwood, John L.
    Fitzjohn, Stephen M.
    Lakics, Viktor
    Malik, Nadia
    Schoeffmann, Stephanie
    O'Neill, Michael J.
    Cheng, Tammy M. K.
    Harris, Laura W.
    Rahmoune, Hassan
    Guest, Paul C.
    Sher, Emanuele
    Collingridge, Graham L.
    Holmes, Elaine
    Tricklebank, Mark D.
    Bahn, Sabine
    NEUROPSYCHOPHARMACOLOGY, 2012, 37 (02) : 364 - 377
  • [10] The Methylazoxymethanol Acetate (MAM-E17) Rat Model: Molecular and Functional Effects in the Hippocampus
    Eva Hradetzky
    Thomas M Sanderson
    Tsz M Tsang
    John L Sherwood
    Stephen M Fitzjohn
    Viktor Lakics
    Nadia Malik
    Stephanie Schoeffmann
    Michael J O'Neill
    Tammy MK Cheng
    Laura W Harris
    Hassan Rahmoune
    Paul C Guest
    Emanuele Sher
    Graham L Collingridge
    Elaine Holmes
    Mark D Tricklebank
    Sabine Bahn
    Neuropsychopharmacology, 2012, 37 : 364 - 377